BioSpace News Archive

EpigenCare Inc., a biotechnology company specializing in consumer epigenetics, launched its new version of its SKINTELLI personalized skincare test. The product, which is a direct-to-consumer DNA test, looks at the current quality of an individual’s skin through epigenetic mechanisms such as DNA methylation. This new version, d

The new agreement will provide Lonza with access to Arbor’s gene editing technology Quote from David Cheng, CEO of Arbor: “Arbor’s differentiated gene editing technologies allow Lonza to manufacture the next generation of therapeutics. Arbor is committed to seeking and working with partners in this field to build an ecosystem for the research, development and manufacturing of biological and cellular therapies.”

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for the Company’s 3-antigen prophylactic hepatitis B vaccine candidate for the prevention of infection caused by all known subtypes

-- VUI-202012/01 Variant May Increase SARS-CoV-2 Transmissibility by 70% -- -- Controls to be Used to Develop, Verify and Validate Tests that Identify More Transmissible Variant --

TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP), is pleased to showcase a highly-valued customer relationship with Merakey Behavioral Health. Merakey provides education, support a

Phylagen, the San Francisco-based biotech company focused on decoding the environmental microbiome for indoor safety was recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment.

Ziopharm Oncology , Inc. (“Ziopharm” or “the Company”) (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the H.C. Wainwright Bioconnect 2021 Conference and will deliver a corporate overview at the 39 th Annual J.P. Morgan Healthcare Conference. H.C. Wainwright Bioconnect 2021 Conference Date: Monday, January 11, 2021 Time: 6:00 am ET (acc

Agency authorized first device indicated to treat patients with necrotic tissue resulting from complications of acute pancreatitis

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, announced today financial and operational business updates. Recent Developments Fourth quarter 2020 net revenue is expected to be approximately $3.5 million, increased from the prior exp

Company launches new website to provide information to customers about vaccine’s safety and availability; initiates campaign to hire nationwide; maintains enhanced cleaning and safety standards